Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Feghali

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Current Rheumatology Reports|March 12, 2005
Genetics and proteomics in sclerodermaCarol A Feghali-Bostwick
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 12, 2005
IGF-I: mediator of fibrosis or carcinogenesis?Carol A Feghali-Bostwick
The Biochemical Journal|September 1, 1995
Ligand-dependent and -independent activation of the transcription factor gamma RF-1 in a cell-free systemC A Feghali, T M Wright
The American Journal of Pathology|May 10, 2008
Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathwaysEileen Hsu, Carol A Feghali-Bostwick
Arthritis and Rheumatism|July 14, 1999
Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosisC A Feghali, T M Wright
Frontiers in Bioscience : a Journal and Virtual Library|January 1, 1997
Cytokines in acute and chronic inflammationC A Feghali, T M Wright
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 7, 2014
Role of endostatin in fibroproliferative disorders.-as a candidate for anti-fibrosis therapy-Yukie Yamaguchi, Carol A Feghali-Bostwick
Frontiers in Pharmacology|June 7, 2014
Fibroblasts in fibrosis: novel roles and mediatorsRyan T Kendall, Carol A Feghali-Bostwick
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 1, 1992
[Intracavernous injections]A Feghali, A Noujeim, R O Fourcade
The Open Rheumatology Journal|July 18, 2012
Insulin-like growth factor binding proteins-3 and -5: central mediators of fibrosis and promising new therapeutic targetsKristen L Veraldi, Carol A Feghali-Bostwick
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Current Rheumatology Reports|March 12, 2005
Genetics and proteomics in sclerodermaCarol A Feghali-Bostwick
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 12, 2005
IGF-I: mediator of fibrosis or carcinogenesis?Carol A Feghali-Bostwick
The Biochemical Journal|September 1, 1995
Ligand-dependent and -independent activation of the transcription factor gamma RF-1 in a cell-free systemC A Feghali, T M Wright
The American Journal of Pathology|May 10, 2008
Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathwaysEileen Hsu, Carol A Feghali-Bostwick
Arthritis and Rheumatism|July 14, 1999
Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosisC A Feghali, T M Wright
Frontiers in Bioscience : a Journal and Virtual Library|January 1, 1997
Cytokines in acute and chronic inflammationC A Feghali, T M Wright
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 7, 2014
Role of endostatin in fibroproliferative disorders.-as a candidate for anti-fibrosis therapy-Yukie Yamaguchi, Carol A Feghali-Bostwick
Frontiers in Pharmacology|June 7, 2014
Fibroblasts in fibrosis: novel roles and mediatorsRyan T Kendall, Carol A Feghali-Bostwick
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 1, 1992
[Intracavernous injections]A Feghali, A Noujeim, R O Fourcade
The Open Rheumatology Journal|July 18, 2012
Insulin-like growth factor binding proteins-3 and -5: central mediators of fibrosis and promising new therapeutic targetsKristen L Veraldi, Carol A Feghali-Bostwick
Pageof 11